लोड हो रहा है...
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
Anti-tumour necrosis factor α (anti-TNFα) therapy is an established treatment in inflammatory bowel disease. However, this treatment is associated with high costs and the possibility of severe adverse events representing a true challenge for patients, clinicians and health care systems. Consequently...
में बचाया:
| में प्रकाशित: | World J Gastroenterol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Baishideng Publishing Group Inc
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4408449/ https://ncbi.nlm.nih.gov/pubmed/25944990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i16.4773 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|